Attainability of ACTH therapy with intramuscular injections twice a week for a period of 9 months, measured as the percentage of injections that has been received in line with the treatment schedule. 9 months [clinicaltrials_resource:3d706e9a5ec378042585b4ca073f2127]
In this open-label study all patients included are treated in the experimental group.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Attainability of ACTH therapy with intramuscular injections twice a week for a period of 9 months, measured as the percentage of injections that has been received in line with the treatment schedule. 9 months [clinicaltrials_resource:3d706e9a5ec378042585b4ca073f2127]
In this open-label study all patients included are treated in the experimental group.
Bio2RDF identifier
3d706e9a5ec378042585b4ca073f2127
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3d706e9a5ec378042585b4ca073f2127
measure [clinicaltrials_vocabulary:measure]
Attainability of ACTH therapy ...... e with the treatment schedule.
time frame [clinicaltrials_vocabulary:time-frame]
description
In this open-label study all patients included are treated in the experimental group.
identifier
clinicaltrials_resource:3d706e9a5ec378042585b4ca073f2127
title
Attainability of ACTH therapy ...... e treatment schedule. 9 months
@en
type
label
Attainability of ACTH therapy ...... 06e9a5ec378042585b4ca073f2127]
@en